Skip to main content
Premium Trial:

Request an Annual Quote

Admera, University of Rochester Partner on PGx Pain Management Study

NEW YORK (GenomeWeb) – Admera Health and the University of Rochester School of Medicine and Dentistry announced today that they have begun enrollment in a clinical study evaluating the use of the company's 50-gene PGxOne Plus pharmacogenomics test in guiding pain management decisions following acute dental surgery.

PGxOne Plus uses next-generation sequencing technology to interrogate genes in order to predict how patients will respond to drug therapy. Reports sent to clinicians include information on whether specific drugs should be avoided, alternative treatments, and dosage adjustments.

The partners specifically aim to see if preoperative use of the test can significantly improve the efficacy of surgical pain management, as well as characterize the association between gene-drug interactions and clinical outcomes. The university will provide patient samples to Admera for analysis.

Additional terms of the deal were not disclosed.

"Most acute surgical pain methods have shown inconsistent effects on pain relief and rely excessively on opioid use, which has associated dependency issues," Admera President and CEO Guanghui Hu said in a statement. "With the implementation of our PGxOne Plus test, we are confident that this study will demonstrate improved patient outcomes, similar to the way pharmacogenomics has been clinically validated in other therapeutic areas."

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.